Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Dharmaj Crop Guard Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Q3FY26 revenue from operations: ₹1,895 million, a 9% year-on-year (YoY) increase from ₹1,745 million in Q3FY25. Key concall takeaways from Dharmaj Crop Guard…
24 Sept 2026
Dharmaj Crop Guard Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Revenue from Operations for Q1 FY27: ₹3,841 Mn, a 5% increase YoY from ₹3,674 Mn in Q1 FY26. Key concall takeaways from Dharmaj Crop Guard Ltd's Q1 FY27…
24 Sept 2026
Anuh Pharma Q2 FY25: Revenue ₹169.35 Cr | Arthneeti
Q2 FY25
Q2 FY25 Revenue: Rs 169.35 Cr (Page 6) . Key concall takeaways from Anuh Pharma Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Anuh Pharma Q4 FY25: Revenue ₹198.14 Cr, PAT ₹12.46 Cr | Arthneeti
Q4 FY25
For Q4 FY 2025, operating revenue was ₹198.14 crore, a 2.24% year-on-year increase from ₹193.63 crore in Q4 FY 2024 (derived from annual total revenue…
24 Sept 2026
Anuh Pharma Q1 FY26: Revenue ₹186.48 Cr, PAT ₹8.30 Cr | Arthneeti
Q1 FY26
Operating Revenue for Q1 FY 2026: ₹186.48 Cr, a 35.22% increase year-on-year from ₹137.91 Cr in Q1 FY 2025. Key concall takeaways from Anuh Pharma Ltd's Q1…
24 Sept 2026
Anuh Pharma Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
185.88 Cr, a -0.32% change quarter-on-quarter; 6 months ended 30/09/2025: Rs. Key concall takeaways from Anuh Pharma Ltd's Q2 FY26 earnings call — and how it…
24 Sept 2026
Anuh Pharma Q3 FY26: Revenue ₹201.18 Cr, PAT ₹13.45 Cr | Arthneeti
Q3 FY26
Q3 FY26 Revenue: ₹201.18 Cr (page 13: Operating Revenue 197.18 + possibly rounding difference clarified on page 6 as ₹201 Cr) . Key concall takeaways from Anuh…
24 Sept 2026
Anuh Pharma Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
202.12 Cr., a 2.50% increase quarter-on-quarter (Page 14) . Key concall takeaways from Anuh Pharma Ltd's Q4 FY26 earnings call — and how it ranks against…
24 Sept 2026
Anuh Pharma Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
193.81 Cr, up 3.93% YoY from Rs. Key concall takeaways from Anuh Pharma Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
24 Sept 2026
Anuh Pharma Q1 FY23 earnings call: Revenue & Margins | Arthneeti
Q1 FY23
116.38 Cr, down 1% YoY from Rs. Key concall takeaways from Anuh Pharma Ltd's Q1 FY23 earnings call — and how it ranks against sector peers.
24 Sept 2026
Anuh Pharma Q3 FY23 earnings call: Revenue & Margins | Arthneeti
Q3 FY23
138.73 Cr, up 21% QoQ (from Rs. Key concall takeaways from Anuh Pharma Ltd's Q3 FY23 earnings call — and how it ranks against sector peers.
24 Sept 2026
Anuh Pharma Q4 FY23 earnings call: Revenue & Margins | Arthneeti
Q4 FY23
157.31 Cr, up from Rs. Key concall takeaways from Anuh Pharma Ltd's Q4 FY23 earnings call — and how it ranks against sector peers.
24 Sept 2026
Anuh Pharma Q1 FY24 earnings call: Revenue & Margins | Arthneeti
Q1 FY24
161.48 Cr., up 39% YoY from Rs. Key concall takeaways from Anuh Pharma Ltd's Q1 FY24 earnings call — and how it ranks against sector peers.
24 Sept 2026
Nelcast Q3 FY24: Revenue ₹323.0 Cr, PAT ₹25.5 Cr | Arthneeti
Q3 FY24
Q3FY24 Total Revenue: ₹323.0 Cr, down 3.2% YoY from ₹333.7 Cr in Q3FY23 (Page 5). Key concall takeaways from Nelcast Ltd's Q3 FY24 earnings call — and how it…
24 Sept 2026
Anuh Pharma Q3 FY24: Capex ₹20 Cr | Arthneeti
Q3 FY24
172.10 Cr, a 15% increase quarter-on-quarter and 31% year-on-year over 9M FY23. Key concall takeaways from Anuh Pharma Ltd's Q3 FY24 earnings call — and how it…
24 Sept 2026
Nelcast Q2 FY25: Revenue ₹335.0 Cr, PAT ₹9.8 Cr | Arthneeti
Q2 FY25
Q2FY25 total revenue: ₹335.0 Cr, down from ₹362.6 Cr in Q2FY24 (approx. Key concall takeaways from Nelcast Ltd's Q2 FY25 earnings call — and how it ranks…
24 Sept 2026
Nelcast Q1 FY27: Revenue ₹345.4 Cr, PAT ₹5.1 Cr | Arthneeti
Q1 FY27
Q1FY27 Total Revenue: ₹345.4 crore, up 2.8% YoY from ₹336.0 crore in Q1FY26 (Page 6, 4) . Key concall takeaways from Nelcast Ltd's Q1 FY27 earnings call — and…
24 Sept 2026
Nelcast Q2 FY24: Revenue ₹362.6 Cr, PAT ₹16.6 Cr | Arthneeti
Q2 FY24
Quarter Revenue (Q2 FY24):** ₹362.6 Cr, up 9.3% YoY from ₹331.7 Cr in Q2 FY23 (Page 5) . Key concall takeaways from Nelcast Ltd's Q2 FY24 earnings call — and…
24 Sept 2026
Rajoo Engineers Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
79.40 crore . Key concall takeaways from Rajoo Engineers Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Rajoo Engineers Q1 FY27: Revenue ₹123.07 Cr, PAT ₹17.35 Cr | Arthneeti
Q1 FY27
Revenue from operations for Q1 FY27 was ₹123.07 crore, up 44.66% YoY from ₹85.07 crore in Q1 FY26 (Page 8). Key concall takeaways from Rajoo Engineers Ltd's Q1…
24 Sept 2026